DEERFIELD, Ill.--(BUSINESS WIRE)--
Baxter International Inc. (NYSE:BAX), a leading global medical products
company, today announced that its Board of Directors has declared a
quarterly cash dividend of $0.19 per share of common stock. The dividend
is payable on October 1, 2018, to stockholders of record as of August
31, 2018. The indicated annual dividend rate is $0.76 per share of
common stock.
About Baxter
Every day, millions of patients and caregivers rely on Baxter’s leading
portfolio of critical care, nutrition, renal, hospital and surgical
products. For more than 85 years, we’ve been operating at the critical
intersection where innovations that save and sustain lives meet the
healthcare providers that make it happen. With products, technologies
and therapies available in more than 100 countries, Baxter’s employees
worldwide are now building upon the company’s rich heritage of medical
breakthroughs to advance the next generation of transformative
healthcare innovations. To learn more, visit www.baxter.com and
follow us on Twitter, LinkedIn and Facebook.
This release includes forward-looking statements concerning Baxter's
dividends and rates thereof. The statements are based on assumptions
about many important factors, including the following, which could cause
actual results to differ materially from those in the forward-looking
statements: continued strength in the company’s financial position,
including cash flows; alternative uses of funds including, but not
limited to dividends, share repurchases, research and development,
business development transactions and other investments in the company’s
businesses; and other risks identified in the company's most recent
filing on Form 10-K and other SEC filings, all of which are available on
Baxter’s website. Baxter does not undertake to update its
forward-looking statements.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180717005598/en/
Media Contact
Bill Rader, (224) 948-5353
media@baxter.com
or
Investor
Contact
Clare Trachtman, (224) 948-3085
Source: Baxter International Inc.